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Materials and Methods
Peptide synthesis and purification.
All peptide synthesis reagents were purchased from AGTC bioproducts Ltd. Peptides were synthesized on a CEM Liberty 1 automated peptide synthesizer on Rink amide MBHA resin (0.25 mmol scale), using standard Fmoc-amino acid solid-phase peptide synthesis protocols 1 and purified and characterized as previously reported, 2 see Figure S1 . Peptide concentrations were determined based on the tryptophan absorbance at 280 nm (ε 280 nm = 5690 M -1 cm -1 ) in 7
M aqueous solutions of guanidinium hydrochloride.
Circular Dichroism (CD) Spectroscopy.
CD spectra were recorded in 1 mm pathlength quartz cuvettes on a Jasco J-715
spectropolarimeter. The observed ellipticity in millidegrees was converted into molar ellipticity, (Θ), and is reported in units of deg dmol -1 cm 2 res -1 . The % folding was calculated based on the theoretical maximum ellipticity value -39054 deg dmol -1 cm 2 res -1 for our coiled coil, based on reports by Scholtz et al. 3 Aliquots of a 1 mM stock solution of GdCl 3 /TbCl 3 , and a 1 M stock solution of CaCl 2 were titrated into either a 100 or 30 μM solution of MB1 peptide monomer in 5 mM HEPES buffer pH 7.0 and the CD spectra recorded after 20 min equilibration. Sedimentation equilibrium experiments could be best fit for a simple monomer-to-trimer model in the presence of Gd(III) (vide infra) and so the CD titration data was fit to the following model,
, where the dissociation constant (K d ), the inverse of the association constant (K a ), can be defined by equation (1).
(1)
In 
Equation (2) can be rearranged to determine the dissociation constant using a non-linear least-squares fitting, solving for total metal concentration, using Kaleidagraph (Synergy Software), see equation (4). equilibrium constants were then determined using SEDPHAT. 4 The specific partial volume was taken to be 0.7571 and the buffer density was approximated to 1.00 using SEDNTERP software (Biomolecular Interaction Technologies Centre, New Hampshire, USA).
Results:
In the absence of Gd(III) the mass obtained from a simple fit assuming single species is slightly higher than would be expected (4733 as compared to monomer mass of 4004 amu). This is indicates a small amount of self-association in the system even in the absence of the Gd(III). To assess this further the data was fit to a monomer-to-trimer model.
This provides a fit that is at least as good as that for the single species fit, however, close examination of the K a for these fits shows the interaction to be very weak (10 -1.5 M -1 ), consistent with the requirement for Gd(III) to drive oligomerisation.
In the presence of Gd(III) ( Figure S3 ) an equivalent fit to a single species model produces a mass which is significantly above that expected for the dimer (9291 amu). These data suggest that the ligand bound complex is likely to contain a significant quantity of trimer. However the observation that the mass is not that of a trimer indicates that the solution contains an equilibrium between a number of species. To assess this, these data were best fit to a monomer-to-trimer equilibrium model with the major species now the trimer.
This model fits well to the data and provides an association constant of 67608297 M -2 . To assess whether other oligomerisation states could explain the behavior of the peptide in the experiment, other models were tested including those describing monomer-to-dimer and monomer-to-tetramer equilibriums. Neither of these models fit these data as well as that for the monomer-to-trimer equilibrium (see Table S1 ).
We are aware that the simple monomer-to-trimer model does not perfectly reflect the proposed assembly mechanism as it does not include the Gd(III). To address this, a more complex stepwise addition model was used to fit these data:
This model also fits to these data, but with a chi 2 value that is slightly worse than that for the simple monomer-to-trimer model (9.4 for the stepwise model compared to 8.3 for the simple monomer-to-trimer). This stepwise model suggests an K a1 association constant for Gd(III) to the first MB1 of 47863 M -3 (see Table S1 ).
Overall these data confirm that the presence of Gd(III) mediates the formation of the Gd(MB1) 3 trimer. The data best fits to a single step trimerisation, although within the limits of the data the more complex sequential assembly cannot be ruled out.
Mass Spectrometry.
Peptides were diluted in 10 mM ammonium acetate to a concentration of 7.38 pmol/µl monomer (2.46 pmol/µl trimer) and 10 pmol/µl GdCl 3 or TbCl 3 . The pH of these solutions were identified to be between 6.5 and 7.0. 10 µl of the sample was collected and sprayed by the use of an Advion Biosciences TriVersa NanoMate electrospray source (Ithaca, NY, USA)
into a Thermo Fisher LTQ Orbitrap Velos mass spectrometer (Bremen, Germany). Mass spectra were acquired in the orbitrap mass analyser at a resolution of 100,000 at m/z 400 and comprised of 30 scans each comprising of 4 co-added microscans.
Luminescence.
Emission spectra were recorded in a 1 cm pathlength quartz cuvette using an Edinburgh
Instruments Fluorescence FLS920 system with a 450 W Xenon arc lamp and a Hamamatsu R928 photomultiplier tube. The emission monochromator was fitted with two interchangeable gratings blazed at 500 nm and 1200 nm and the data was collected using equivalences of MB1, prepared in 10 mM HEPES pH 7.0. The higher concentrations and excess of peptide (6 monomers per Gd(III)) was used to ensure that >99% of Gd(III) was bound at the lowest concentration (50 µM), see Figure S4 . produced from a series of 9 spin echo images with varying T 1 inversion recovery delays from 6 -3500 ms and RARE factor of 1. T 2 relaxation maps were produced from 8 echo images with echo times from 103 -1516 ms and a RARE factor of 64.
Molecular Dynamics Simulations.
The Gd(III)-coiled coil model was built using Insight II (Biosym/MSI, San Diego, California), modifying amino acids from the previously published three-stranded coiled-coil structure 3H5F 8 and solvated with a water box at least 15 Å larger than the peptide in all dimensions. As the Gd(III)-coiled coil is neutral, no counterions were required. Minimization and molecular dynamic simulations were carried out using AMBER v8.0 9 with the ff03 10 forcefield, with additional parameters for Gd 3+ . Gd 3+ ions were treated as simple spheres with a charge of +3 and Van der Waals parameters (MOD4 RE format in AMBER) r = 1.7131
(radius) and e = 0.459789 (well depth). Prior to data-gathering dynamics, the peptide was subjected to 100000 cycles of conjugate gradient minimization and 500 ps equilibration dynamics at 300 K, with constant volume and periodic boundary conditions. Data gathering ran for 10.0 ns also at 300K, with constant volume and periodic boundary conditions, taking snapshots every 10 ps. concentration, for T 1 relaxation rates Gd(MB1) 3 (blue diamonds) and Dotarem® (green triangles), and T 2 relaxation rates Gd(MB1) 3 (red squares) and Dotarem® (purple circles). Gd(MB1) 3 solutions are at higher concentrations and contain excess peptide (6 equivalents MB1 per Gd(III)), so as to ensure that >99% of Gd(III) is present as Gd(MB1) 3 . Data recorded at 293 K in 10 mM HEPES buffer pH 7.0 at 300 MHz, and relaxivity values calculated from gradient. 
